SIDE EFFECTS
Adverse Reactions From Clinical Trials
There are no data available on adverse reactions from Baxalta-sponsored clinical trials conducted with BUMINATE 25%.
Post-Marketing Adverse Reactions
The following adverse reactions have been reported in the post-marketing experience.
Immune System Disorders : Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions
Nervous System Disorders : Headache, dysgeusia
Cardiac Disorders : Myocardial infarction, atrial fibrillation, tachycardia
Vascular Disorders : Hypotension, flushing
Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, dyspnea
Gastrointestinal Disorders : Vomiting, nausea
Skin and Subcutaneous Tissue Disorders : Urticaria, rash, pruritus
General Disorders and Administration Site Conditions : Pyrexia, chills
